Article
Development and external validation of a clinical-genetic risk identification model for rheumatoid arthritis-associated interstitial lung disease.
Frontiers in immunology - 1 Jan 2026
Fan Wei, Bo Wei, Yu Xuanhua, Gao Xiaojuan, Huang Jinmei, Zhang Yi, Wu Shufan, Chen Xuyan, Lu Liangjing, Yin Hanlin
Abstract excerpt
Objective: This study aimed to develop and externally validate a clinical risk identification model for prevalent rheumatoid arthritis-associated interstitial lung disease (RA-ILD) using multicenter Chinese patient cohorts. We also evaluated the discriminative value of MUC5B polymorphisms (rs35705950 and rs868903) in a combined clinical-genetic model for this purpose. Methods: A multicenter, two-phase design was...
Read the complete abstract on PubMedTopics
- Humans
